RxDoctor Payments Data

Laurie Friedland, APRN

Adult Health · Henderson, NVNPI 1396306486

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Amgen at 30.3% of the total. Reporting peaked in 2023 at $958 and has fallen 80.4% since, to $188 in 2025.

$2,493in general payments, 2019–2025

Across 49 payments — averaging $50.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$755
  • Cvrx, Inc.$296
  • Abiomed$256
  • Boehringer Ingelheim$210
  • Boston Scientific$202
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$173
  • plus $600 from 7 others

What the payments were for

  • Food & beverage$2,493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,493 in reported general payments places this provider in the 75th percentile of 90 adult health providers in Nevada.

See all adult health providers in Nevada

Medicare billing

Part B allowed, 2024
$5,744
Medicare patients
73
Services billed
89

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban11$6,173
Atorvastatin Calcium19$144
ClopidogrelClopidogrel Bisulfate23$125
Carvedilol15$49

Paid to pharmacies, not to this prescriber.

Other adult health in Henderson

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →